ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

CEFERINO VILLA FUERTE MD

200 SMITH DRIVE ADIRONDACK CLINIC

Corinth | New York | 12822

(518) 654-7680

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,150Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 131

$892K Total Retail Price of All Prescriptions

Rank: 9 out of 131

218 Patients Receiving at Least One Drug in Part D
25%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 218 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 3,392 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
POLYETHYLENE GLYCOL 3350 798 235 1 47
SIMVASTATIN 551 185 2 1
LEVOTHYROXINE SODIUM 480 153 3 5
OMEPRAZOLE 396 133 4 4
ALENDRONATE SODIUM 346 76 5 23
DIVALPROEX SODIUM 272 32 6 50
CALCITONIN-SALMON 267 139 10 7 169
NEXIUM 251 62 8 16
CARBAMAZEPINE 200 63 9 148
FUROSEMIDE 185 54 10 3
SYNTHROID 176 49 11 71
RISPERIDONE 167 48 12 42
METOCLOPRAMIDE HCL 147 55 13 154
LEVETIRACETAM 138 39 14 37
TAMSULOSIN HCL 137 95 15 24
METOPROLOL TARTRATE 132 46 16 7
THIORIDAZINE HCL 127 26 R 17 230
QUETIAPINE FUMARATE 124 36 18 43
LISINOPRIL 119 78 19 6
LACTULOSE 119 45 19 54
METOPROLOL SUCCINATE 119 47 19 10
TRICOR 118 29 22 203
OLANZAPINE 114 29 23 99
FLUTICASONE PROPIONATE 111 41 24 78
DILANTIN 106 35 25 246
NIASPAN 105 15 26 100
FORTEO 99 37 27 251
RANITIDINE HCL 92 35 28 35
POTASSIUM CHLORIDE 91 33 29 29
HYDROCHLOROTHIAZIDE 83 35 30 12
SERTRALINE HCL 81 45 31 27
PRIMIDONE 81 21 31 272
AMLODIPINE BESYLATE 80 43 33 2
SILVER SULFADIAZINE 77 16 34 105
LAMOTRIGINE 77 25 34 175
EVISTA 73 34 36 119
BACLOFEN 69 0 37 128
HALOPERIDOL 68 48 38 88
CLONIDINE HCL 67 0 39 72
SEROQUEL 66 12 40 91
ABILIFY 65 16 41 110
FENOFIBRATE 63 13 42 124
AMITIZA 58 13 43 159
ZOLPIDEM TARTRATE 58 0 43 15
AMOX TR-POTASSIUM CLAVULANATE 57 25 45 173
PREVACID 57 19 45 211
DIOVAN 57 42 45 30
ZYPREXA 56 14 48 318
FINASTERIDE 56 44 48 77
MUPIROCIN 54 0 50 82
LITHIUM CARBONATE 52 0 51 325
CHLORPROMAZINE HCL 51 13 52 329
TOPIRAMATE 51 0 52 249
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.